77 related articles for article (PubMed ID: 9741974)
1. Recent advances in cyclic nucleotide phosphodiesterases. Part 1 of 2. Proceedings of a symposium. Glasgow, Scotland, July 18-25, 1996.
Cell Biochem Biophys; 1998; 29(1-2):1-201. PubMed ID: 9741974
[No Abstract] [Full Text] [Related]
2. Cyclic nucleotides and phosphodiesterases in platelets.
Haslam RJ; Dickinson NT; Jang EK
Thromb Haemost; 1999 Aug; 82(2):412-23. PubMed ID: 10605732
[No Abstract] [Full Text] [Related]
3. Recent advances in the study of Ca2+/CaM-activated phosphodiesterases: expression and physiological functions.
Zhao AZ; Yan C; Sonnenburg WK; Beavo JA
Adv Second Messenger Phosphoprotein Res; 1997; 31():237-51. PubMed ID: 9344255
[No Abstract] [Full Text] [Related]
4. Multiple forms of cyclic nucleotide phosphodiesterases: anomalies or biologic regulators?
Strada SJ; Thompson WJ
Adv Cyclic Nucleotide Res; 1978; 9():265-83. PubMed ID: 208379
[No Abstract] [Full Text] [Related]
5. Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases.
Fischmeister R; Castro LR; Abi-Gerges A; Rochais F; Jurevicius J; Leroy J; Vandecasteele G
Circ Res; 2006 Oct; 99(8):816-28. PubMed ID: 17038651
[TBL] [Abstract][Full Text] [Related]
6. The biology of cyclic nucleotide phosphodiesterases.
Adv Second Messenger Phosphoprotein Res; 1992; 25():1-416. PubMed ID: 1343557
[No Abstract] [Full Text] [Related]
7. [Active role of phosphodiesterases in regulation of cyclic AMP metabolism in the thyroid gland (proceedings)].
Erneux C; Boeynaems JM; Van Sande J; Dumont JE
Arch Int Physiol Biochim; 1976 Dec; 84(5):1070-2. PubMed ID: 65996
[No Abstract] [Full Text] [Related]
8. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung.
Fertel R; Weiss B
Mol Pharmacol; 1976 Jul; 12(4):678-87. PubMed ID: 183099
[No Abstract] [Full Text] [Related]
9. Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized.
Manganiello V
Mol Pharmacol; 2003 Jun; 63(6):1209-11. PubMed ID: 12761329
[No Abstract] [Full Text] [Related]
10. Cyclic nucleotide specific phosphodiesterases of the kinetoplastida: a unified nomenclature.
Kunz S; Beavo JA; D'Angelo MA; Flawia MM; Francis SH; Johner A; Laxman S; Oberholzer M; Rascon A; Shakur Y; Wentzinger L; Zoraghi R; Seebeck T
Mol Biochem Parasitol; 2006 Jan; 145(1):133-5. PubMed ID: 16280178
[No Abstract] [Full Text] [Related]
11. Cyclic nucleotide phosphodiesterases (PDEs): diverse regulators of cyclic nucleotide signals and inviting molecular targets for novel therapeutic agents.
Manganiello VC; Degerman E
Thromb Haemost; 1999 Aug; 82(2):407-11. PubMed ID: 10605731
[No Abstract] [Full Text] [Related]
12. Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors.
Castro A; Jerez MJ; Gil C; Martinez A
Med Res Rev; 2005 Mar; 25(2):229-44. PubMed ID: 15514991
[TBL] [Abstract][Full Text] [Related]
13. Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases.
Baillie GS
FEBS J; 2009 Apr; 276(7):1790-9. PubMed ID: 19243430
[TBL] [Abstract][Full Text] [Related]
14. [Cyclic nucleotide phosphodiesterases in rat pancreas].
Robberecht P; Deschodt-Lanckman M; De Neef P; Christophe J
Arch Int Physiol Biochim; 1973 Sep; 81(3):593. PubMed ID: 4127518
[No Abstract] [Full Text] [Related]
15. Phosphodiesterases and cyclic nucleotide signaling in endocrine cells.
Conti M
Mol Endocrinol; 2000 Sep; 14(9):1317-27. PubMed ID: 10976911
[No Abstract] [Full Text] [Related]
16. Participation of peripheral and spinal phosphodiesterases 4 and 5 in inflammatory pain.
Torres-López JE; Argüelles CF; Granados-Soto V
Proc West Pharmacol Soc; 2002; 45():141-3. PubMed ID: 12434560
[No Abstract] [Full Text] [Related]
17. Regulation of hormone efficacy in isolated hepatocytes by the intracellular redox state acting on cyclic AMP phosphodiesterase [proceedings].
Clark MG; Filsell OH; Garrett IG
J Physiol; 1976 Dec; 263(1):175P-176P. PubMed ID: 189012
[No Abstract] [Full Text] [Related]
18. Evolution of aortic and cardiac cyclic AMP phosphodiesterase during the onset of mineralpcorticoid hypertension in the rat [proceedings].
Lugnier C; Michon T; Stoclet JC
Br J Pharmacol; 1976 Nov; 58(3):434P-435P. PubMed ID: 186145
[No Abstract] [Full Text] [Related]
19. Hormonal regulation of cyclic nucleotide phosphodiesterases.
Conti M; Jin SL; Monaco L; Repaske DR; Swinnen JV
Endocr Rev; 1991 Aug; 12(3):218-34. PubMed ID: 1657587
[No Abstract] [Full Text] [Related]
20. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
Rybalkin SD; Bornfeldt KE
Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
[No Abstract] [Full Text] [Related]
[Next] [New Search]
